Ensign Group Shares Gain On Mixed Q4 Results, Better-Than-Expected FY22 Outlook

Provider of post-acute healthcare services, The Ensign Group Inc's  ENSG Q4 FY21 sales increased 10.2% Y/Y to $693.1 million, missing the consensus of $698.33 million.

  • Ensign reported an adjusted EPS of $0.97 ahead of the consensus of $0.96.
  • Total skilled services segment income increased to $100.2 million, +19.1%.
  • Same-store and transitioning occupancy increased by 3.0% and 6.8%, respectively, from the prior-year quarter. 
  • Real estate segment income was $9.4 million, an increase of 7.3% Y/Y. FFO was $14.7 million, up 10.2%.
  • The Company's liquidity remains strong with approximately $262.2 million cash on hand and $343.3 million of available capacity under its line of credit.
  • The Company also announced a new stock repurchase program for 2022 of $20 million. 
  • Guidance: For FY22, Ensign expects EPS of $4.01 - $4.13, compared to the consensus of $3.94, with sales of $2.93 billion - $2.98 billion versus the consensus of $2.89 billion. 
  • The new midpoint of this 2022 earnings guidance represents an increase of 12% over 2021 results and is 30% higher than 2020 results. 
  • Price Action: ENSG shares are up 4.38% at $78.28 during the market session on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceHealth CareMoversTrading IdeasGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!